 ATLANTA, Dec. 28, 2020 PRNewswire -- Inhibikase Therapeutics, Inc. Nasdaq: IKT Inhibikase, a clinical-stage pharmaceutical company developing therapeutics for Parkinsons disease and related disorders that arise inside and outside of the brain, announced today the closing of its... 